Completed NA INTERVENTIONAL 2-arm NCT01166308

Carbon Ion Radiotherapy for Recurrent Gliomas (CINDERELLA)

Randomised Phase I/II Study to Evaluate Carbon Ion Radiotherapy Versus Fractionated Stereotactic Radiotherapy in Patients With Recurrent or Progressive Gliomas: The CINDERELLA Trial

Sponsor: University Hospital Heidelberg

Conditions Glioma

Interventions Carbon Ion Radiotherapy Fractionated Stereotactic Radiotherapy (FSRT)

Updated 5 times since 2017 Last updated: May 11, 2018 Started: Dec 31, 2010 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glioma, this trial is completed. The trial is conducted by University Hospital Heidelberg and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE1_PHASE2 → NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Heidelberg

Data source: University Hospital Heidelberg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Germany